Home

Actuate Therapeutics, Inc. - Common stock (ACTU)

6.7000
-0.5200 (-7.20%)
NASDAQ · Last Trade: Apr 4th, 1:03 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 28, 2025
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · December 13, 2024
Pheton, Powell Max Make Public Debuttalkmarkets.com
Pheton Holdings and Powell Max opened for trading on Thursday at $3.76 and $4.30, respectively. While the number of initial public offerings has rebounded from 2023, IPOs remain well below pre-pandemic levels.
Via Talk Markets · September 8, 2024
Actuate Therapeutics Makes Public Debuttalkmarkets.com
Actuate Therapeutics opened on Aug. 13 at $9.88. The biopharmaceutical company had priced its initial public offering of 2.8 million shares at a price of $8.00 per share.
Via Talk Markets · August 18, 2024